Cancer Treatment-induced Bone Loss in the Elderly: Progress and Ongoing Challenges

Intern Med. 2023 Jul 15;62(14):2035-2036. doi: 10.2169/internalmedicine.1368-22. Epub 2023 Jan 15.
No abstract available

Keywords: androgen deprivation therapy; aromatase inhibitor; bisphosphonate; chronic kidney disease; denosumab; treatment gap.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Androgen Antagonists
  • Bone Density
  • Bone Density Conservation Agents* / adverse effects
  • Breast Neoplasms*
  • Denosumab
  • Diphosphonates
  • Female
  • Humans
  • Longitudinal Studies

Substances

  • Denosumab
  • Bone Density Conservation Agents
  • Diphosphonates
  • Androgen Antagonists